SMI Expanded
1.876,02
PKT
+12,69
PKT
+0,68
%
Werbung
Analysen zu SMI Expanded-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 17.08.06 | Nestlé buy | Bank Sarasin & Cie | |
| 16.08.06 | Swiss Life buy | SRC Research | |
| 16.08.06 | Swiss Life buy | Merck Finck & Co | |
| 16.08.06 | Swiss Life outperform | HypoVereinsbank | |
| 17.08.06 | Swisscom buy | Merrill Lynch | |
| 16.08.06 | Swiss Life halten | AC Research | |
| 15.08.06 | UBS halten | Helaba Trust | |
| 15.08.06 | UBS halten | Helaba Trust | |
| 16.08.06 | UBS kaufen | National-Bank AG | |
| 16.08.06 | Zurich Insurance overweight | Lehman Brothers | |
| 15.08.06 | UBS buy | SEB | |
| 15.08.06 | Swiss Life Outperformer | LB Rheinland-Pfalz | |
| 15.08.06 | Adecco SA buy | Bank Sarasin & Cie | |
| 10.08.06 | Swiss Life neutral | JP Morgan | |
| 08.08.06 | Givaudan neutral | HypoVereinsbank | |
| 07.08.06 | Holcim neutral | Goldman Sachs | |
| 03.08.06 | Holcim verkaufen | Helaba Trust | |
| 03.08.06 | Clariant underperform | HypoVereinsbank | |
| 03.08.06 | UBS halten | Helaba Trust | |
| 04.08.06 | UBS neutral | Goldman Sachs | |
| 03.08.06 | Adecco SA übergewichten | Zürcher Kantonalbank | |
| 03.08.06 | Novartis buy | Banc of America Sec. | |
| 03.08.06 | Clariant halten | Helaba Trust | |
| 02.08.06 | Novartis buy | Banc of America Sec. | |
| 02.08.06 | Logitech buy | First Albany | |
| 02.08.06 | Novartis Buy | Banc of America Sec. | |
| 03.08.06 | UBS buy | Bank Sarasin & Cie | |
| 03.08.06 | UBS buy | Merrill Lynch | |
| 01.08.06 | Holcim | Bank Hofmann | |
| 01.08.06 | UBS overweight | JP Morgan | |
| 28.07.06 | UBS | DZ-Bank | |
| 28.07.06 | Richemont kaufen | National-Bank AG | |
| 28.07.06 | ABB (Asea Brown Boveri) kaufen | National-Bank AG | |
| 31.07.06 | ABB (Asea Brown Boveri) overweight | JP Morgan | |
| 27.07.06 | ABB (Asea Brown Boveri) verkaufen | Helaba Trust | |
| 28.07.06 | Richemont halten | Hamburger Sparkasse | |
| 25.07.06 | Novartis buy | Banque SYZ & CO | |
| 24.07.06 | UBS overweight | JP Morgan | |
| 24.07.06 | UBS overweight | JP Morgan | |
| 24.07.06 | Novartis kaufen | Independent Research |